Today: 8 April 2026

Quantum Computing Inc (QUBT) Stock Skyrockets on $500M Fundraising and New Tech Debut – Can the Rally Last?

Quantum Computing Inc (QUBT) Soars 24% on $500M Funding & New “Quantum Secure” Tech – Will It Hit $40?

Quantum Computing Inc. raised $500 million in an oversubscribed private placement in late September, boosting total cash to about $850 million. QUBT shares spiked 24% on Oct. 3 after unveiling a new quantum encryption platform at ECOC 2025, but remain volatile. Analysts raised targets, with Ascendiant Capital now at $40. Despite a $19.98 close on Oct. 2 and strong market cap, Q2 revenue was just $61,000 with a $36.5 million net loss.
Lithium Americas (LAC) Soars as US Govt Takes 5% Stake – Analysts Weigh In on EV Lithium Boom

U.S. Govt Bets on “White Gold”: Lithium Americas Stock Explodes as DOE Takes Stake

Lithium Americas (LAC) stock jumped over 20–30% to new 52-week highs after announcing a $2.26 billion U.S. DOE loan partnership, with trading volume spiking to nearly five times normal. The company’s market cap stands near $2 billion, despite minimal revenue and a $24.8 million H1 loss, supported by $509 million in cash. Construction advances at Thacker Pass, with first steel installed and 300 workers on site. Analyst consensus remains Hold, with price targets averaging $5.
Dow Soars to Record as Fed Cut Fever Grips Wall Street – Nasdaq Sags on Tech Slide – US Stock Market Today

Dow Soars to Record as Fed Cut Fever Grips Wall Street – Nasdaq Sags on Tech Slide – US Stock Market Today

The Dow Jones closed up 0.8% at a record 46,873.59 and the S&P 500 gained 0.2% to 6,726.74 on October 3, while the Nasdaq slipped 0.2% after early highs. Utilities led sector gains as tech stocks lagged, with Nvidia down 1.6% and Tesla off 3.3%. Lithium Americas surged nearly 30% after a U.S. government equity deal. Rate-cut hopes and weak economic data drove trading amid a continued government shutdown.
iPhone 17 Unveiled: Apple’s New Flagship Stuns with Bigger Screen, Smarter Camera & All-Day Battery Life

iPhone 17 vs. iPhone 16: Is Apple’s New Flagship a Game-Changer or Just Hype?

iPhone 17 Pro introduces a unibody aluminum chassis, a wide camera plateau, and drops the titanium frame seen in iPhone 16 Pro. The 17 Pro debuts the A19 Pro chip, three 48-MP rear cameras with 8× optical zoom, and a 120Hz ProMotion display on all models. Battery life on the 17 Pro Max reaches up to 39 hours of video playback, compared to about 30 hours on the 16 Pro Max.
Beats Powerbeats Fit Unveiled: Wingtip Redesign Makes Apple’s New $200 Earbuds a Workout Game-Changer

Beats Powerbeats Fit Unveiled: Wingtip Redesign Makes Apple’s New $200 Earbuds a Workout Game-Changer

Apple’s Beats brand released the Powerbeats Fit wireless earbuds today for $199.99, replacing the Beats Fit Pro under the Powerbeats name. The new model features redesigned silicone wingtips for improved comfort and a smaller charging case, but retains the same battery life and Apple H1 chip. Powerbeats Fit is available in four colors and supports both iOS and Android devices.
3 October 2025
MicroStrategy (MSTR) on Oct. 2 2025: Why the Bitcoin Treasury King Keeps Making Headlines

MicroStrategy (MSTR) Stock Skyrockets on Crypto Tax Break – Is a 50% Rally Next?

Strategy Inc. (formerly MicroStrategy) traded near $355 at midday Oct 3, up 0.8%, after closing Oct 2 at $352.33 on heavy volume and wide swings. The company reported record Q2 net income of $10 billion, driven by a $14 billion unrealized Bitcoin gain. It holds about 640,000 BTC and continues aggressive purchases. IRS guidance this week exempts its crypto gains from the new corporate minimum tax.
QuantumScape (QS) Stock Skyrockets 14% on Solid-State EV Battery Breakthrough – Can the Rally Continue?

QuantumScape (QS) Stock Skyrockets 14% on Solid-State EV Battery Breakthrough – Can the Rally Continue?

QuantumScape shares surged 14.3% intraday Oct. 3 to $16.35, just below their 52-week high, after announcing a partnership with Corning to co-develop ceramic separator technology. The stock is up 172% year-to-date but analysts remain bearish, with a consensus “Sell” rating and a $5.88 average 12-month price target. Trading volume is elevated, and technical resistance remains near $15.
Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?

Rolls-Royce Rockets 40%+ in 2 Years: Jet Engine Boom and £11B Submarine Deal Fuel Rally

Rolls-Royce shares hit 1,176p mid-day Oct 3, 2025, near an all-time high and up 124% in 12 months. Q3 orders reached £8.5bn, up 22% year-on-year, driven by civil and defense contracts. FY2024 revenue rose 15% to £18.9bn; underlying operating profit climbed 55% to £2.5bn. UBS and others raised price targets after strong results and resumed dividends.
Vietnam’s Crypto Gold Rush: Binance, Bybit & Korean Custodian BDACS Supercharge Da Nang’s Digital Finance Hub

Bitcoin Surges Past $120K in “Uptober” Rally – Is a New ATH Looming?

Bitcoin surged above $120,000 for the first time since August 2025, reaching nearly $121,000 on Oct. 2 before settling near $119,000–$120,000. U.S. spot Bitcoin ETFs saw record inflows, with $676 million on Oct. 1 and $627 million on Oct. 2, pushing total ETF assets over $59 billion. Ethereum rose to $4,467, while MicroStrategy added 196 BTC, raising its holdings to 640,031 BTC.
Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Humana shares jumped over 6% to $272.05 midday Oct 3 after the company reported a sharp rise in Medicare Advantage star ratings for 2026. The stock rebounded from last week’s drop, which followed news of Humana cutting its Medicare Advantage footprint. Wall Street consensus remains neutral, with a $289 average price target. Year-to-date, shares are flat and about 19% below their 52-week high.
3 October 2025
Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (CDTX) Stock Soars After $339M BARDA Flu-Drug Deal – Is CD388 the Next Big Flu-Fighter?

Cidara shares jumped 5.7% to $104.13 Friday morning, nearing a 52-week high after winning a BARDA award worth up to $339 million for its flu drug CD388. The stock is up over 200% year-to-date, with analysts raising price targets as high as $173. Cidara reported $516.9 million in cash and a Q2 net loss of $25.7 million. Short interest stands at 11.3% of float.
🚀 CleanSpark (CLSK) Stock Surges on $120K Bitcoin Rally and $200M Crypto Credit Boost

🚀 CleanSpark (CLSK) Stock Surges on $120K Bitcoin Rally and $200M Crypto Credit Boost

CleanSpark shares rose 6.3% to $16.10 midday Oct. 3, with volume spiking to 13.7 million, far above the three-month average. The company announced two new $100 million bitcoin-backed credit lines this week, bringing total crypto-backed lending to $400 million. CleanSpark holds about 13,011 BTC and operates a 50 EH/s mining fleet. Analyst consensus rates the stock a moderate buy, with an average 12-month target of $20.36.
Coal Comeback Sends Peabody Energy (BTU) Stock Soaring – Real-Time Update & Analyst Insights

Coal Comeback Sends Peabody Energy (BTU) Stock Soaring – Real-Time Update & Analyst Insights

Peabody Energy shares rose about 5.9% to $31 Friday morning, with heavy trading volume. The company faces arbitration from Anglo American after walking away from a $3.78 billion coal asset deal. Peabody reported a Q2 net loss of $27.6 million but holds net cash of $192 million. Analysts remain mixed, with a consensus “Moderate Buy” and average 12-month target of $22–24.
3 October 2025
Eos Energy (EOSE) Stock Skyrockets on Big Moves – What’s Fueling the Surge?

Eos Energy (EOSE) Stock Skyrockets on Big Moves – What’s Fueling the Surge?

Eos Energy (NASDAQ: EOSE) surged 22% this week, hitting multi-year highs near $12 as trading volumes spiked. Q2 revenue reached a record $15.2 million, with shipments up 122% quarter-over-quarter. Insiders, including the CEO and CFO, sold shares in Q3, and the company filed to issue 7.33 million new shares on Oct 2. Wall Street remains mixed, with most analysts rating the stock “Hold.”
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health shares traded near $19.81 midday Oct. 3, up about 2.8%, with a market cap around $4.9 billion. The company reported Q2 revenue of $2.86 billion and a $228 million net loss, serving about 2 million members, mostly in ACA exchanges. On Sep. 11, Oscar announced a $350 million convertible note offering to fund growth and retire its credit line. Analyst ratings remain cautious, with recent downgrades citing ACA risk.
3 October 2025
Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

Iris Energy Rockets to Record High Amid AI Mining Frenzy – Is the Rally Sustainable?

Iris Energy (IREN) traded near $49.00 on Oct. 3, up 4.2% intraday and near a record high after surging nearly 500% in a year. The company doubled its AI cloud GPU fleet to 23,000 and posted FY2025 revenue of $501 million, up 168% year-over-year. Analysts raised price targets to as high as $82, though JPMorgan cited valuation risks. IREN now outpaces peers Marathon and Riot in both market cap and stock gains.
White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

White Mountains shares surged about 9.3% to $1,820 midday Oct. 3 after announcing a $1.75 billion sale of its Bamboo insurance platform to CVC Capital. The deal brings in roughly $840 million in cash and adds about $310 to book value per share. Year-to-date, WTM stock remains down 5.7%. CEO Manning Rountree will retire at year-end, with President/CFO Liam Caffrey set to succeed him.
Sandisk (SNDK) Stock Report – October 3, 2025

Sandisk (SNDK) Stock Report – October 3, 2025

SanDisk’s flash-memory division spun off from Western Digital and relisted as NASDAQ:SNDK on Feb. 24, 2025. Shares surged over 215% year-to-date, closing at $124 on Oct. 3 with a $19.7 billion market cap. The company opened a new 218-layer flash fab in Japan and increased data-center sales to 12% of revenue. Analysts rate the stock a strong buy, but warn of high valuation and industry cyclicality.
Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data

Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data

GRAL shares surged to $69.14 intraday on Oct 3, up nearly 6.8% and about 248% year-to-date. Market cap reached $2.3–2.5 billion, a 472% jump since mid-2024, despite ongoing losses and negative EPS. Wall Street consensus remains “Hold” with a $31.50 average price target, far below current levels. Investors await new PATHFINDER 2 trial data at ESMO Congress later this month.
Opendoor Stock Surges on Shopify COO Move – Will AI Magic Keep It Rising?

Opendoor Stock Surges on Shopify COO Move – Will AI Magic Keep It Rising?

Opendoor shares surged 6.8% to $8.56 mid-morning Oct. 3, up about 401% year-to-date after appointing Kaz Nejatian as CEO and announcing AI-driven plans. Q2 revenue reached up to $1.6 billion with a $23 million adjusted EBITDA profit, but weak Q3 guidance sent the stock down 11% in August. Wall Street remains skeptical, with an average 12-month price target of $1.26.

Stock Market Today

  • Paramount Skydance Shares Surge 10.7% Amid Strong Consumer Momentum
    April 8, 2026, 6:53 AM EDT. Paramount Skydance (PSKY) shares jumped 10.7% to $10.9 on higher trading volume, rebounding from a 12% decline over four weeks. The surge reflects accelerating direct-to-consumer growth, a strengthened content lineup, and a robust UFC partnership. Management reaffirmed its full-year revenue and profitability outlook. The company anticipates Q2 earnings of $0.22 per share, a 24.1% decline year-over-year, with revenues rising 0.7% to $7.24 billion. Despite this, earnings estimates have been revised down 6.2% in the past month, which usually signals downward pressure on stock prices. PSKY holds a Zacks Rank #3 (Hold). Investors should watch if the recent rally signals sustained gains amid mixed earnings forecasts.
Go toTop